Cargando…
Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis
BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) is a degenerative interstitial lung disease with both a poor prognosis and quality of life once the diagnosis is made. In the last decade many features of the disease have been investigated to better understand the pathological steps that lead to the o...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176704/ https://www.ncbi.nlm.nih.gov/pubmed/34088304 http://dx.doi.org/10.1186/s12890-021-01550-2 |
_version_ | 1783703300474929152 |
---|---|
author | Lacedonia, Donato Scioscia, Giulia Soccio, Piera Conese, Massimo Catucci, Lucia Palladino, Grazia P. Simone, Filomena Quarato, Carla M. I. Di Gioia, Sante Rana, Roberto Sollitto, Francesco Foschino-Barbaro, Maria P. |
author_facet | Lacedonia, Donato Scioscia, Giulia Soccio, Piera Conese, Massimo Catucci, Lucia Palladino, Grazia P. Simone, Filomena Quarato, Carla M. I. Di Gioia, Sante Rana, Roberto Sollitto, Francesco Foschino-Barbaro, Maria P. |
author_sort | Lacedonia, Donato |
collection | PubMed |
description | BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) is a degenerative interstitial lung disease with both a poor prognosis and quality of life once the diagnosis is made. In the last decade many features of the disease have been investigated to better understand the pathological steps that lead to the onset of the disease and, moreover, different types of biomarkers have been tested to find valid diagnostic, prognostic and therapy response predictive ones. In the complexity of IPF, microRNA (miRNAs) biomarker investigation seems to be promising. METHODS: We analysed the expression of five exosomal miRNAs supposed to have a role in the pathogenesis of the disease from serum of a group of IPF patients (n = 61) and we compared it with the expression of the same miRNAs in a group of healthy controls (n = 15). RESULTS: In the current study what emerged is let-7d down-regulation and, unexpectedly, miR-16 significant down-regulation. Moreover, through a cross-sectional analysis, a clustering of the expression of miR-16, miR-21 and miR-26a was found. CONCLUSIONS: These findings could help the individuation of previously unknown key players in the pathophysiology of IPF and, most interestingly, more specific targets for the development of effective medications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-021-01550-2. |
format | Online Article Text |
id | pubmed-8176704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81767042021-06-04 Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis Lacedonia, Donato Scioscia, Giulia Soccio, Piera Conese, Massimo Catucci, Lucia Palladino, Grazia P. Simone, Filomena Quarato, Carla M. I. Di Gioia, Sante Rana, Roberto Sollitto, Francesco Foschino-Barbaro, Maria P. BMC Pulm Med Research Article BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) is a degenerative interstitial lung disease with both a poor prognosis and quality of life once the diagnosis is made. In the last decade many features of the disease have been investigated to better understand the pathological steps that lead to the onset of the disease and, moreover, different types of biomarkers have been tested to find valid diagnostic, prognostic and therapy response predictive ones. In the complexity of IPF, microRNA (miRNAs) biomarker investigation seems to be promising. METHODS: We analysed the expression of five exosomal miRNAs supposed to have a role in the pathogenesis of the disease from serum of a group of IPF patients (n = 61) and we compared it with the expression of the same miRNAs in a group of healthy controls (n = 15). RESULTS: In the current study what emerged is let-7d down-regulation and, unexpectedly, miR-16 significant down-regulation. Moreover, through a cross-sectional analysis, a clustering of the expression of miR-16, miR-21 and miR-26a was found. CONCLUSIONS: These findings could help the individuation of previously unknown key players in the pathophysiology of IPF and, most interestingly, more specific targets for the development of effective medications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-021-01550-2. BioMed Central 2021-06-04 /pmc/articles/PMC8176704/ /pubmed/34088304 http://dx.doi.org/10.1186/s12890-021-01550-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Lacedonia, Donato Scioscia, Giulia Soccio, Piera Conese, Massimo Catucci, Lucia Palladino, Grazia P. Simone, Filomena Quarato, Carla M. I. Di Gioia, Sante Rana, Roberto Sollitto, Francesco Foschino-Barbaro, Maria P. Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis |
title | Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis |
title_full | Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis |
title_fullStr | Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis |
title_full_unstemmed | Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis |
title_short | Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis |
title_sort | downregulation of exosomal let-7d and mir-16 in idiopathic pulmonary fibrosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176704/ https://www.ncbi.nlm.nih.gov/pubmed/34088304 http://dx.doi.org/10.1186/s12890-021-01550-2 |
work_keys_str_mv | AT lacedoniadonato downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT sciosciagiulia downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT socciopiera downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT conesemassimo downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT catuccilucia downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT palladinograziap downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT simonefilomena downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT quaratocarlami downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT digioiasante downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT ranaroberto downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT sollittofrancesco downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis AT foschinobarbaromariap downregulationofexosomallet7dandmir16inidiopathicpulmonaryfibrosis |